| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive model based on temporal dynamics of peripheral T cell repertoire for predicting post-treatment distant metastasis of nasopharyngeal carcinoma
|
Zhang, Yajing
|
|
|
71 |
3 |
p. 675-688
|
artikel
|
| 2 |
An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors
|
Wu, Pu
|
|
|
71 |
3 |
p. 747-759
|
artikel
|
| 3 |
Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials
|
Landre, Thierry
|
|
|
71 |
3 |
p. 719-726
|
artikel
|
| 4 |
A secondary role for hypoxia and HIF1 in the regulation of (IFNγ-induced) PD-L1 expression in melanoma
|
van Duijn, Anneloes
|
|
|
71 |
3 |
p. 529-540
|
artikel
|
| 5 |
Chemotherapy: a double-edged sword in cancer treatment
|
Behranvand, Nafiseh
|
|
|
71 |
3 |
p. 507-526
|
artikel
|
| 6 |
Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection
|
Chen, Xiuxing
|
|
|
71 |
3 |
p. 661-674
|
artikel
|
| 7 |
Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors
|
Kang, Da Hyun
|
|
|
71 |
3 |
p. 579-588
|
artikel
|
| 8 |
Comparison of time to failure of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy: a consecutive analysis of patients having NSCLC with high PD-L1 expression
|
Takumida, Hiroshi
|
|
|
71 |
3 |
p. 737-746
|
artikel
|
| 9 |
Correction to: Chemotherapy: a double‑edged sword in cancer treatment
|
Behranvand, Nafiseh
|
|
|
71 |
3 |
p. 527
|
artikel
|
| 10 |
Effect of HLA genotype on intravesical recurrence after bacillus Calmette–Guérin therapy for non-muscle-invasive bladder cancer
|
Kobayashi, Mizuki
|
|
|
71 |
3 |
p. 727-736
|
artikel
|
| 11 |
Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody
|
Mateu-Albero, Tamara
|
|
|
71 |
3 |
p. 627-636
|
artikel
|
| 12 |
Efficacy and safety of PD-L1 inhibitors versus PD-1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer
|
Yu, Hui
|
|
|
71 |
3 |
p. 637-644
|
artikel
|
| 13 |
Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma
|
Mizuno, Tomoya
|
|
|
71 |
3 |
p. 565-578
|
artikel
|
| 14 |
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21
|
Thangaraj, Jaya Lakshmi
|
|
|
71 |
3 |
p. 613-625
|
artikel
|
| 15 |
Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia
|
Zhang, Xian
|
|
|
71 |
3 |
p. 689-703
|
artikel
|
| 16 |
Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq
|
Zhuang, Hongkai
|
|
|
71 |
3 |
p. 601-612
|
artikel
|
| 17 |
ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas
|
Xu, Houshi
|
|
|
71 |
3 |
p. 645-660
|
artikel
|
| 18 |
Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma
|
Ohira, Masahiro
|
|
|
71 |
3 |
p. 589-599
|
artikel
|
| 19 |
Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
|
Hoffmann, Elgin
|
|
|
71 |
3 |
p. 541-552
|
artikel
|
| 20 |
The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells
|
Kung, Pin-Jui
|
|
|
71 |
3 |
p. 705-718
|
artikel
|
| 21 |
Transcriptomic signatures of tumors undergoing T cell attack
|
Gokuldass, Aishwarya
|
|
|
71 |
3 |
p. 553-563
|
artikel
|
Tijdschrift beschrijving